ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 56 of 57
УЖМБС 2020, 5(1): 354–359

Expression of Long Non-Coding RNAs in Long-term Adaptation to Intense Physical Training

Polishchuk A. O. 1, Drozdovska S. B. 1, Goncharov S. V. 2, Dosenko V. E. 2

Despite the fact that physical activity is one of the most reliable means of preventing a number of cardiovascular diseases, and high levels of physical activity are strictly associated with reducing the incidence of these diseases, excessive physical activity can be a factor that provokes their development. In addition, the risk of their development is contributed by genetic factors that explain the heterogeneity of the impact of exercise on the body. Although the qualitative and quantitative indicators of the manifestation of myocardial hypertrophy have been sufficiently studied and classified, the discussions about the mechanisms of formation of hypertrophy and the possibility of transformation of physiological hypertrophy into pathological under the influence of physical activity are still silent. A new class of RNAs is long non-coding RNAs (lncRNAs) associated with a wide variety of biological processes in response to physical activity that can act on different stages of gene expression. Some authors demonstrated in experiments the important role of lncRNA in the normal development of the heart and in the occurrence of heart disease, in particular, it was shown that some long non-coding RNAs were expressed by myocardium and might be factors of cardiac hypertrophy. The purpose of the study was to investigate the response of changes in lncRNA expression levels as a possible mechanism of adaptation to intense physical activity. Material and methods. The study involved 153 individuals, 111 of them were professional athletes (82 were rowers, 29 were athletes), 12 were non-professional and 30 were untrained individuals, who formed the control group. In our study we used the following methods: analysis of scientific literature, molecular-genetic (RNA isolation, real-time PCR), methods of mathematical statistics. Results and discussion. In the situation with non-professional athletes (marathon runners), we did not get reliable results, although lncRNA expression levels vary. Immediately after moderate exercise, the expression of LIPCAR lncRNA decreased 1.02-fold (p=0.61) and increased 1.28-fold (p = 0.43) above rest on the 1st day. Expression of NRON lncRNA was similar to LIPCAR initially decreasing 1.04 times (p=0.56) and resuming within 24 hours – from the first point increasing 1.02 times (p=0.88). In both cases, the level of MHRT lncRNA increased 1.25 times (p=0.67) immediately after the marathon race, and 1.34 times (p=0.32) after 24 hours. MIAT expression changes slightly decreasing 1.28 times (p=0.35), slightly increasing after several days by 1.15 times (p=0.47). After moderate exercise, the expression of most lncRNAs (LIPCAR, NRON, and MIAT) decreased slightly, but recovered somewhat after 24 hours, which may indicate a super-compensation phenomenon, whereas MHRT levels increased in both cases. Conclusion. Studies of their expression level in response to physical activity allowed us to reveal new aspects of the regulation mechanism of the adaptive response of the cardiovascular system to physical activity. Expression of non-coding RNA genes may be a potential information marker of the progress of adaptation processes to intense physical activity.

Keywords: long noncoding RNA, cardiac hypertrophy, physical exercise

Full text: PDF (Ukr) 218K

  1. Bezugla VV. Kardiomiopatiya vnaslidok fizychnogo perevantazhennya [Cardiomyopathy due to physical overload]. Zhurnal klinichnykh ta eksperymentalnykh medychnykh doslidzhen. 2016; 4(2): 226-36. [Ukrainian]
  2. Belotserkovskyy ZB. Serdechnaya deyatelnost y funktsyonalnaya podgotovlennost u sportsmenov (norma y atypychnye yzmenenyya v normalnykh y yzmenennykh uslovyyakh adaptatsyy k fyzycheskym nagruzkam) [Cardiac activity and functional readiness in athletes (norm and atypical changes in normal and altered conditions of adaptation to physical activity)]. M: Sovetskyy sport; 2012. 548 p. [Russian]
  3. Gavrylova EA. Stressornaya kardymyopatyya u sportsmenov [Stressor cardiomyopathy in athletes]. European researcher. 2012; 22(6-2): 961-3. [Russian]
  4. Nie M, Deng Z-L, Liu J, Wang D-Z. Noncoding RNAs, emerging regulators of skeletal muscle development and diseases. BioMed Research International. 2015; 2015: 676575. PMID: 26258142. PMCID: PMC4516831.
  5. Drozdovska SB, Polishchuk AO. Uchast nekoduyuchykh RNK (ncRNA) u formuvanni gipertrofiyi miokardu pry m’yazoviy diyalnosti [Involvement of noncoding RNAs (ncRNAs) in the formation of myocardial hypertrophy in muscle activity]. Visnyk problem biologiyi i medytsyny. 2017; 3(141): 38-43. [Ukrainian]
  6. Li D, Chen G, Yang J, Fan X, Gong Y, Xu G, et al. Transcriptome analysis reveals distinct patterns ofl ong noncoding RNAs in heart and plasma of mice with heart failure. PLoS One. 2013 Oct 29; 8(10): e77938. PMID: 24205036. PMCID: PMC3812140.
  7. Yang KC, Yamada KA, Patel AY, Topkara VK, George I, Cheema FH, et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 2014; 129(9): 1009–21. PMID: 24429688. PMCID: PMC3967509.
  8. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation. 2000; 101(19): 2271–6. PMID: 10811594.
  9. From AM, Scott CG, Chen HH. Changes in diastolic dysfunction in diabetes mellitus over time. Am J Cardiol. 2009; 103(10): 1463–6. PMID: 19427447. PMCID: PMC2700297.
  10. de Gonzalo-Calvo D, Kenneweg F, Bang C, Toro R, van der Meer RW, Rijzewijk LJ, et al. Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes. Sci Rep. 2016; 6: 37354. PMID: 27874027. PMCID: PMC5118808.
  11. Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet. 2006; 51: 1087–99. PMID: 17066261.
  12. Zhang J, Gao C, Meng M, Tang H. Long Noncoding RNA MHRT Protects Cardiomyocytes against H2O2-Induced Apoptosis. Biomol Ther (Seoul). 2016 Jan; 24(1): 19–24. PMID: 26759697. PMCID: PMC4703348.
  13. Kumarswamy R, Thum T. Non-coding RNAs in cardiac remodeling and heart failure. Circ Res. 2013; 113: 676–89. PMID: 23989712.
  14. Han P, Li W, Lin CH, Yang J, Shang C, Nuernberg ST, et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 2014; 514: 102–6. PMID: 25119045. PMCID: PMC4184960.